1. Sphingosine 1-phosphate: A Potential Molecular Target for Ovarian Cancer Therapy?
   Lan Dai et al, 2014, Cancer Investigation CrossRef
2. Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation
   C Kao et al, 2014, Cell Death & Disease CrossRef
3. Expansion of Sphingosine Kinase and Sphingosine-1-Phosphate Receptor Function in Normal and Cancer Cells: From Membrane Restructuring to Mediation of Estrogen Signaling and Stem Cell Programming
   Olga Sukocheva, 2018, International Journal of Molecular Sciences CrossRef
4. Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary
   Ryoko Takahashi et al, 2016, PLOS ONE CrossRef
5. Effects of Pleiotrophin (PTN) on the resistance to paclitaxel in ovarian cancer cells
   Li Yunfei et al, 2023, Journal of Radiology and Oncology CrossRef
6. Autophagy as an emerging therapy target for ovarian carcinoma
   Lei Zhan et al, 2016, Oncotarget CrossRef
7. PP2A: The Wolf in Sheep’s Clothing?
   Maeve Kiely et al, 2015, Cancers CrossRef
8. The emerging role of FTY720 (Fingolimod) in cancer treatment
   Christopher White et al, 2016, Oncotarget CrossRef
9. Targeting S1PR1 May Result in Enhanced Migration of Cancer Cells in Bladder Carcinoma
   Chin-Li Chen et al, 2021, Cancers CrossRef
10. Drug combination in vivo using combination index method: Taxotere and T607 against colon carcinoma HCT-116 xenograft tumor in nude mice
    Jianing Fu et al, 2016, Synergy CrossRef
11. Targeting PP2A in cancer: Combination therapies
    Sahar Mazhar et al, 2019, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research CrossRef
12. xCT expression modulates cisplatin resistance in Tca8113 tongue carcinoma cells
    PENG ZHANG et al, 2016, Oncology Letters CrossRef
13. Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer
    Jeong‐Won Lee et al, 2015, International Journal of Cancer CrossRef
14. FTY720 induces autophagy-related apoptosis and necroptosis in human glioblastoma cells
    Li Zhang et al, 2015, Toxicology Letters CrossRef
15. Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer
    Hyun-Soo Kim et al, 2015, Oncotarget CrossRef
16. The inhibition of autophagy by spautin boosts the anticancer activity of fingolimod in multidrug-resistant hepatocellular carcinoma
    Dima W. Alhamad et al, 2022, Life Sciences CrossRef
17. More than Just an Immunosuppressant: The Emerging Role of FTY720 as a Novel Inducer of ROS and Apoptosis
    Teruaki Takasaki et al, 2018, Oxidative Medicine and Cellular Longevity CrossRef
18. Molecular Pharmacology and Novel Potential Therapeutic Applications of Fingolimod
    Safura Pournajaf et al, 2022, Frontiers in Pharmacology CrossRef
19. Targeting Sphingolipids for Cancer Therapy
    Osmel Companioni et al, 2021, Frontiers in Oncology CrossRef
20. FTY720 enhances the anti-tumor activity of carboplatin and tamoxifen in a patient-derived xenograft model of ovarian cancer
    Kelly M. Kreitzburg et al, 2018, Cancer Letters CrossRef
21. Phyllanthusmin Derivatives Induce Apoptosis and Reduce Tumor Burden in High-Grade Serous Ovarian Cancer by Late-Stage Autophagy Inhibition
    Alexandria N. Young et al, 2018, Molecular Cancer Therapeutics CrossRef
22. Increased autophagy in EOC re-ascites cells can inhibit cell death and promote drug resistance
    Yu Liu et al, 2018, Cell Death & Disease CrossRef